The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial
Open accessAbstract
BACKGROUND: Cervical cancer screening coverage remains insufficient in most countries. Our objective was to assess whether in-home vaginal self-sampling with a dry swab for high-risk human papillomavirus (HR-HPV) testing is effective and cost-effective in increasing participation in cervical cancer screening. METHODS: In March 2012, 6000 unscreened women aged 30-65 years, living in a French region covered by a screening programme, who had not responded to an initial invitation to have a Pap smear were equally randomised to three groups: 'no intervention'; 'recall', women received a letter to have a Pap smear; and 'self-sampling', women received a self-sampling kit to return to a centralised virology laboratory for PCR-based HPV testing. RESULTS: Participation was higher in the 'self-sampling' than in the 'no intervention' group (22.5% vs 9.9%, P<0.0001; OR 2.64) and 'recall' group (11.7%, P<0.0001; OR 2.20). In the 'self-sampling' group, 320 used the self-sampling kit; for 44 of these women with positive HR-HPV test results, 40 had the recommended triage Pap smear. The ICER per extra screened woman was 77.8[euro ] and 63.2[euro ] for the 'recall' and 'self-sampling' groups, respectively, relative to the 'no intervention' group. CONCLUSIONS: Offering an in-home, return-mail kit for vaginal self-sampling with a dry swab is more effective and cost-effective than a recall letter in increasing participation in cervical cancer screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Three (12%) of the 25 trials met the criteria for low risk of bias in all categories.114 115 117”
From Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses (2018) · cites this paper as [115]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Hoffmann, T. C., Glasziou, P. P., Boutron, I., Milne, R., Perera, R., Moher, D., Altman, D. G., Barbour, V., Macdonald, H., Johnston, M., et al. (2014) · BMJ · doi:10.1136/bmj.g1687 · Cited by 10,548
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>
Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104
Boutron, I., Moher, D., Altman, D. G., Schulz, K. F., Ravaud, P., & for the CONSORT Group* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00008 · Cited by 2,292
Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities
Gakidou, E., Nordhagen, S., & Obermeyer, Z. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050132 · Cited by 976
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897
The 2001 Bethesda System: Terminology for Reporting Results of Cervical Cytology
Solomon, D., Davey, D. D., Kurman, R. J., Moriarty, A. T., O’Connor, D., Prey, M. U., Raab, S. S., Sherman, M. E., Wilbur, D. C., & Wright, T. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200208000-00015 · Cited by 822
Arbyn, M., Anttila, A., Jordan, J. A., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 762
Arbyn, M., Verdoodt, F., Snijders, P. J. F., Verhoef, V. M. J., Suonio, E., Dillner, L., Minozzi, S., Bellisario, C., Banzi, R., Zhao, F.-H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70570-9 · Cited by 674
Flagged first, then by citations
Research works printed but not linked: 1
- Duport N, Salines E, Grémy I (2014) [First results of the experimental evaluation of the French organized cervical cancer screening program, 2010–2012]. Bull Epidémiol Hebd 13-14-15: 228–234.
Cited by
Sorted by citations
Arbyn, M., Smith, S. B., Temin, S., Sultana, F., & Castle, P. (2018) · BMJ · doi:10.1136/bmj.k4823 · Cited by 851
Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis
Yeh, P. T., Kennedy, C. E., Vuyst, H. D., & Narasimhan, M. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2018-001351 · Cited by 348
Verdoodt, F., Jentschke, M., Hillemanns, P., Racey, C. S., Snijders, P. J. F., & Arbyn, M. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.07.006 · Cited by 275
Musa, J., Achenbach, C. J., O’Dwyer, L. C., Evans, C. T., McHugh, M., Hou, L., Simon, M. A., Murphy, R. L., & Jordan, N. (2017) · PLOS ONE · doi:10.1371/journal.pone.0183924 · Cited by 223
Rapid review of evaluation of interventions to improve participation in cancer screening services
Duffy, S. W., Myles, J. P., Maroni, R., & Mohammad, A. (2016) · Journal of Medical Screening · doi:10.1177/0969141316664757 · Cited by 165
Gupta, S., Palmer, C., Bik, E. M., Cárdenas, J. P., Núñez, H., Kraal, L., Bird, S. W., Bowers, J., Smith, A. J., Walton, N. A., et al. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00077 · Cited by 163
Costa, S., Verberckmoes, B., Castle, P. E., & Arbyn, M. (2023) · British Journal of Cancer · doi:10.1038/s41416-022-02094-w · Cited by 139
Molecular Detection Methods in HPV-Related Cancers
Williams, J., Kostiuk, M. A., & Biron, V. L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.864820 · Cited by 125
Cost-effectiveness studies of HPV self-sampling: A systematic review
Malone, C., Barnabas, R. V., Buist, D. S. M., Tiro, J. A., & Winer, R. L. (2020) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105953 · Cited by 106
McDowell, M. J., Pardee, D. J., Peitzmeier, S. M., Reisner, S. L., Agénor, M., Alizaga, N. M., Bernstein, I. M., & Potter, J. E. (2017) · LGBT Health · doi:10.1089/lgbt.2016.0187 · Cited by 102
Seay, J., Ranck, A., Weiss, R. E., Salgado, C. J., Fein, L. A., & Kobetz, E. K. (2017) · LGBT Health · doi:10.1089/lgbt.2016.0143 · Cited by 88
Remme, M., Narasimhan, M., Wilson, D. P., Ali, M., Vijayasingham, L., Ghani, F., & Allotey, P. A. (2019) · BMJ · doi:10.1136/bmj.l1228 · Cited by 79
Kunckler, M., Schumacher, F., Kenfack, B., Catarino, R., Viviano, M., Tincho, E., Tebeu, P. M., Temogne, L., Vassilakos, P., & Petignat, P. (2017) · Cancer Medicine · doi:10.1002/cam4.1089 · Cited by 80
Gennaro, G. D., Licata, F., Trovato, A., & Bianco, A. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1003461 · Cited by 73
Interventions targeted at women to encourage the uptake of cervical screening
Staley, H., Shiraz, A., Shreeve, N., Bryant, A., Martin‐Hirsch, P. L., & Gajjar, K. B. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002834.pub3 · Cited by 61
Ma'som, M., Bhoo‐Pathy, N., Nasir, N. H., Bellinson, J., Subramaniam, S., Ma, Y., Yap, S. H., Goh, P., Gravitt, P. E., & Woo, Y. L. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-011022 · Cited by 61
Cadman, L., Reuter, C., Jitlal, M., Kleeman, M., Austin, J., Hollingworth, T., Parberry, A. L., Ashdown-Barr, L., Patel, D., Nedjai, B., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1226 · Cited by 60
Acceptability and feasibility of human papilloma virus self-sampling for cervical cancer screening
Ilangovan, K., Kobetz, E., Koru-Sengul, T., Marcus, E. N., Rodriguez, B., Alonzo, Y., & Carrasquillo, O. (2016) · Journal of Women's Health · doi:10.1089/jwh.2015.5469 · Cited by 56
A non-invasive tool for detecting cervical cancer odor by trained scent dogs
Guerrero-Flores, H., Apresa-García, T., Garay, Ó., Sánchez-Pérez, A., Flores-Villegas, D., Bandera-Calderón, A., García-Palacios, R., Rojas-Sánchez, T. M. D. R., Romero-Morelos, P., Sánchez-Albor, V., et al. (2017) · BMC Cancer · doi:10.1186/s12885-016-2996-4 · Cited by 56
Smith, J. S., Marais, A. C. D., Deal, A. M., Richman, A. R., Perez‐Heydrich, C., Yen‐Lieberman, B., Barclay, L. B., Belinson, J. L., Rinas, A., & Brewer, N. T. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000681 · Cited by 55
Domgue, J. F., Futuh, B., Ngalla, C., Kakute, P., Manjuh, F., Manga, S. M., Nulah, K. L., Welty, E. R., Schmeler, K. M., & Welty, T. (2019) · International Journal of Cancer · doi:10.1002/ijc.32746 · Cited by 54
Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model
Hu, J., Budgeon, L. R., Cladel, N. M., Balogh, K. K., Myers, R. L., Cooper, T. K., & Christensen, N. D. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000295 · Cited by 48
Kellen, E., Benoy, I., Vanden Broeck, D., Martens, P., Bogers, J., Haelens, A., & Van Limbergen, E. (2018) · International Journal of Cancer · doi:10.1002/ijc.31391 · Cited by 48
Shin, H. Y., Lee, B., Hwang, S., Lee, D. O., Sung, N. Y., Park, J. Y., & Jun, J. K. (2019) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2019.30.e76 · Cited by 49
Aarnio, R., Östensson, E., Olovsson, M., Gustavsson, I. M., & Gyllensten, U. B. (2020) · BMC Cancer · doi:10.1186/s12885-020-07085-9 · Cited by 48
Gustavsson, I. M., Aarnio, R., Berggrund, M., Hedlund‐Lindberg, J., Strand, A.-S., Sanner, K., Wikström, I., Enroth, S., Olovsson, M., & Gyllensten, U. B. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.485 · Cited by 42
Offering self-sampling to cervical screening non-attenders in primary care
Lim, A. W., Hollingworth, A., Kalwij, S., Curran, G., & Sasieni, P. D. (2016) · Journal of Medical Screening · doi:10.1177/0969141316639346 · Cited by 33
Peñaranda, E., Molokwu, J., Flores, S., Byrd, T. L., Brown, L. D., & Shokar, N. K. (2015) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000134 · Cited by 31
Self-Collection for Cervical Cancer Screening in a Safety-Net Setting
Montealegre, J. R., Hilsenbeck, S. G., Bulsara, S., Parker, S., Amboree, T. L., Anderson, M. L., Daheri, M., Jibaja‐Weiss, M. L., Schmeler, K. M., Deshmukh, A. A., et al. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.2971 · Cited by 35
Vassilakos, P., Poncet, A., Catarino, R., Viviano, M., Petignat, P., & Combescure, C. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.01.021 · Cited by 29
Peeters, E., Cornet, K., Devroey, D., & Arbyn, M. (2020) · Papillomavirus Research · doi:10.1016/j.pvr.2020.100194 · Cited by 27
Organised Versus Opportunistic Cervical Cancer Screening in Urban and Rural Regions of Lithuania
Paulauskienė, J., Ivanaūskienė, R., Skrodenienė, E., & Petkevičienė, J. (2019) · Medicina · doi:10.3390/medicina55090570 · Cited by 26
Organised screening for cervical cancer in France: a cost-effectiveness assessment
Barré, S., Massetti, M., Leleu, H., & BELS, F. D. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014626 · Cited by 24
Self-sampling for HPV testing in cervical cancer screening: A scoping review
Colonetti, T., Uggioni, M. L. R., dos Santos, A. L. M., Uggioni, N. M., Elibio, L. U., Balbinot, E. L., Grande, A. J., & da Rosa, M. I. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.02.032 · Cited by 32
Phoolcharoen, N., Kantathavorn, N., Krisorakun, W., Taepisitpong, C., Krongthong, W., & Saeloo, S. (2018) · Journal of Community Health · doi:10.1007/s10900-017-0460-2 · Cited by 24
Lilliecreutz, C., Karlsson, H., & Holm, A. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235202 · Cited by 24
Citizen science as an instrument for women’s health research
Ahannach, S., Hoyweghen, I. V., Verhoeven, V., & Lebeer, S. (2024) · Nature Medicine · doi:10.1038/s41591-024-03371-2 · Cited by 18
Meenan, R. T., Troja, C., Buist, D. S. M., Tiro, J. A., Lin, J. W., Anderson, M. L., Gao, H., Green, B. B., & Winer, R. L. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.4052 · Cited by 20
Tranberg, M., Bech, B. H., Blaakær, J., Jensen, J. S., Svanholm, H., & Andersen, B. S. (2016) · BMC Cancer · doi:10.1186/s12885-016-2859-z · Cited by 20
Virtanen, A., Anttila, A., & Nieminen, P. (2015) · BMC Women s Health · doi:10.1186/s12905-015-0261-7 · Cited by 19
The Vaginal Immunoproteome for the Prediction of Spontaneous Preterm Birth
Shaffer, Z., Romero, R. J., Tarca, A. L., Galaz, J., Arenas‐Hernandez, M., Gudicha, D. W., Chaiworapongsa, T., Jung, E., Suksai, M., Gotsch, F., et al. (2022) · eLife · doi:10.7554/elife.90943 · Cited by 19
Xu, H., Yu, Y., George, W., Smith, J. S., Hu, S., Dang, L., Zhang, X., Pan, Q., Qiao, Y., & Zhao, F. (2019) · Journal of Medical Virology · doi:10.1002/jmv.25597 · Cited by 17
Zhang, L., Xu, X., Hu, S., Chen, F., Zhang, X., Pan, Q., Zhang, W., Feng, R., Dong, L., Zhang, Q., et al. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.09.012 · Cited by 15
Effah, K., Tekpor, E., Wormenor, C. M., Allotey, J., Owusu–Agyeman, Y., Kemawor, S., Agyiri, D., Amenu, J., Gmanyami, J. M., Adjuik, M., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-13113-9 · Cited by 14
Molokwu, J., Peñaranda, E., Dwivedi, A. K., Mallawaarachchi, I. V., & Shokar, N. K. (2018) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000424 · Cited by 14
Cervical cancer is not just a young woman's disease
Sherman, S. M., Castañón, A., Moss, E. L., & Redman, C. W. E. (2015) · BMJ · doi:10.1136/bmj.h2729 · Cited by 14
Raginel, T., Grandazzi, G., Launoy, G. D., Trocmé, M., Christophe, V., Berchi, C., & Guittet, L. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-05479-w · Cited by 13
Fujita, M., Nagashima, K., Shimazu, M., Suzuki, M., Tauchi, I., Sakuma, M., Yamamoto, S., Hanaoka, H., Shozu, M., Tsuruoka, N., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0286909 · Cited by 15
Pillay, J., Gates, A., Guitard, S., Zakher, B., Sim, S., Vandermeer, B. W., & Hartling, L. (2025) · Systematic Reviews · doi:10.1186/s13643-025-02866-4 · Cited by 14
Nyitray, A. G., Schick, V., Swartz, M. D., Giuliano, A. R., Fernández, M. E., Deshmukh, A. A., Ridolfi, T. J., Ajala, C., Brzezinski, B., Sandoval, M. N., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-051118 · Cited by 12
Lefeuvre, C., Pauw, H. D., Banaszuk, A.-S., Pivert, A., Ducancelle, A., Rexand-Galais, F., & Arbyn, M. (2022) · International Journal of Public Health · doi:10.3389/ijph.2022.1604284 · Cited by 12
Bruegl, A. S., Emerson, J. B., & Tirumala, K. S. (2022) · Gynecologic Oncology · doi:10.1016/j.ygyno.2022.11.007 · Cited by 12
Paulauskienė, J., Štelemėkas, M., Ivanaūskienė, R., & Petkevičienė, J. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16245035 · Cited by 12
Bertucci, M., Bonnet, E., Satger, L., Kreiche, A., Chappert, J.-L., Loy-Morel, S., Segondy, M., Daurès, J. P., & Boulle, N. (2020) · Women & Health · doi:10.1080/03630242.2020.1831683 · Cited by 12
Fujita, M., Nagashima, K., Shimazu, M., Suzuki, M., Tauchi, I., Sakuma, M., Yamamoto, S., Hanaoka, H., Shozu, M., Tsuruoka, N., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-18800-w · Cited by 10
Impact of postal correspondence letters on participation in cancer screening: a rapid review
Yakubu, M., Meggetto, O., Lai, Y., Peirson, L., Walker, M. J., & Lofters, A. (2020) · Preventive Medicine · doi:10.1016/j.ypmed.2020.106404 · Cited by 10
Knauss, T., Hansen, B. T., Pedersen, K., Aasbø, G., Kunst, N., & Burger, E. A. (2022) · Gynecologic Oncology · doi:10.1016/j.ygyno.2022.10.027 · Cited by 10
Waheed, D.-E.-N., Weil-Olivier, C., Riethmuller, D., Franco, E. L., Prétet, J., Baay, M. F. D., Muñóz, N., & Vorsters, A. (2023) · BMC Proceedings · doi:10.1186/s12919-023-00271-0 · Cited by 10
Phoolcharoen, N., Kantathavorn, N., Krisorakun, W., Sricharunrat, T., Teerayathanakul, N., Taepisitpong, C., Sornsamdang, G., Krongthong, W., & Saeloo, S. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3241-9 · Cited by 10
Bonniec, A. L., Sauvaget, C., Lucas, E., Nassiri, A., & Selmouni, F. (2025) · JMIR Cancer · doi:10.2196/70251 · Cited by 9
Evolving HPV diagnostics: current practice and future frontiers
Shi, L., Chen, H., Zhang, Z., Wang, Y., Ren, W., & Huang, J. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1681779 · Cited by 13
Cost-Effectiveness of HPV Self-Testing Options for Cervical Cancer Screening
Meenan, R. T., Lacey, C., Buist, D. S. M., Tiro, J. A., Lin, J. W., Anderson, M. L., Green, B. B., & Winer, R. L. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.34960 · Cited by 8
Sun, L. J., Patel, S., Fiorina, C., Glass, A., Rochaix, L., Bardou, M., Andersen, B. S., Kirkegaard, P., Bøje, R. B., Tranberg, M., et al. (2023) · The European Journal of Health Economics · doi:10.1007/s10198-023-01627-1 · Cited by 9
Feltri, G., Valenti, G., Isidoro, E., Kaur, J., Treleani, M., Bartelloni, A., Mauro, C., Spiga, F., Ticich, G., Napoli, M. D., et al. (2023) · European journal of medical research · doi:10.1186/s40001-023-01263-8 · Cited by 9
Selmouni, F., Guy, M., Muwonge, R., Nassiri, A., Lucas, E., Basu, P. S., & Sauvaget, C. (2022) · JMIR Research Protocols · doi:10.2196/39288 · Cited by 8
High Rate of β-Globin DNA Detection Validates Self-Sampling in Herpes Simplex Virus Shedding Studies
Mujugira, A., Huang, M.-L. W., Selke, S., Drolette, L. M., Magaret, A., & Wald, A. (2015) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000374 · Cited by 7
Assessment of HPV screening modalities within primary care: a systematic review
Waly, Y. M., Sharafeldin, A.-B. K., Al‐Majmuei, A., Alatoom, M., Fredericks, S., & Aloia, A.-A. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1567509 · Cited by 7
Hassine, A., Antoni, G., Fender, M., Slama, K., Léandri, F.-X., Fanon, J., Auvray, C., Jaffar‐Bandjee, M., Traversier, N., Fagour, L., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-065952 · Cited by 6
Bohn, J. A., Fitch, K. C., Currier, J. J., & Bruegl, A. S. (2022) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2022-003860 · Cited by 6
Howard, M. F., Fyffe-Freil, R., Pierre, C. C., Maku, H. O., Costanzo, S. D., Lorey, T. S., & Greene, D. N. (2025) · Journal of Clinical Microbiology · doi:10.1128/jcm.00767-24 · Cited by 5
Sundqvist, A., Hellsten, C., Strander, B., Lindh, M., & Borgfeldt, C. (2025) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.15112 · Cited by 5
Franck, J.-E., Ringa, V., Rigal, L., Sassenou, J., Cœuret-Pellicer, M., Chauvin, P., & Menvielle, G. (2020) · Journal of Medical Screening · doi:10.1177/0969141320914323 · Cited by 5
Fujita, M., Shimazu, M., Nagashima, K., Suzuki, M., Tauchi, I., Sakuma, M., Yamamoto, S., Shozu, M., Hanaoka, H., Tsuruoka, N., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-049803 · Cited by 5
Appidi, T., Vakada, M., Buddhiraju, H. S., Chinchulkar, S. A., Kota, A., Yadav, D. N., Kodandapani, S., Simhabhatla, S. K., & Rengan, A. K. (2023) · Diagnostics · doi:10.3390/diagnostics13081382 · Cited by 4
Mammalian Species-Specific Resistance to Mammary Cancer
Barash, I. (2025) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-025-09578-4 · Cited by 4
Bouassa, R. M., Gubavu, C., Veyer, D. L., Robin, L., Gravier, A., Hocqueloux, L., Prazuck, T., Péré, H., Bélec, L., for the ANRS ImmiPap Study Group, et al. (2020) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-020-01074-7 · Cited by 6
Boyard, J., Caille, A., Brunet-Houdard, S., Sengchanh, S., Giraudeau, B., Marret, H., Rolland-Lozachmeur, G., Rüsch, E., Gaudy‐Graffin, C., & Haguenoer, K. (2022) · Journal of Women s Health · doi:10.1089/jwh.2021.0597 · Cited by 4
Self-citationFujita, M., Nagashima, K., Shimazu, M., Suzuki, M., Tauchi, I., Sakuma, M., Yamamoto, S., Hanaoka, H., Shozu, M., Tsuruoka, N., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.34970 · Cited by 8
Monitoring mouse papillomavirus-associated cancer development using longitudinal Pap smear screening
Atkins, H., Uslu, A. A., Li, J. J., Shearer, D. A., Brendle, S. A., Han, C., Kozak, M., Lopez, P. G., Nayar, D., Balogh, K. K., et al. (2024) · mBio · doi:10.1128/mbio.01420-24 · Cited by 4
Giubbi, C., Martinelli, M., Meo, M. L. D., Njoku, R. C., Perdoni, F., Fruscio, R., Landoni, F., & Cocuzza, C. E. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31032 · Cited by 4
Fitch, K. C., Bohn, J. A., Emerson, J. B., Boniface, E. R., & Bruegl, A. S. (2023) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2023-004935 · Cited by 3
National organization of uterine cervical cancer screening and social inequality in France
Raginel, T., Mil, R. D., Garnier, A., Launoy, G. D., & Guittet, L. (2019) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000557 · Cited by 3
Goff, J. L., Duc-Banaszuk, A.-S. L., Lefeuvre, C., Pivert, A., Ducancelle, A., Pauw, H. D., Arbyn, M., Vinay, A., & Rexand-Galais, F. (2024) · Cancers · doi:10.3390/cancers16112066 · Cited by 6
Could Urine Testing Be the Future of Cervical Cancer Screening?
Pathak, N., Dodds, J. P., & Zamora, J. (2015) · Women s Health · doi:10.2217/whe.15.21 · Cited by 3
Screening for atrial fibrillation with or without general practice involvement: a controlled study
Modi, R. N., Massou, E., Charlton, P. H., Dymond, A., Williams, K. M., Brimicombe, J. D., Freedman, B., Griffin, S. J., Hobbs, R. F., Lip, G. Y. H., et al. (2025) · BMC Family Practice · doi:10.1186/s12875-025-02878-y · Cited by 2
Chandra, S., Patel, M. V., Shah, K., & Trivedi, K. (2025) · The Indian Journal of Medical Research · doi:10.25259/ijmr_1770_2024 · Cited by 2
Plotti, F., Ficarola, F., Fais, G., Nardone, C. D. C., Montera, R., Luvero, D., Cundari, G. B., Avian, A., Riva, E., Castriciano, S., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155569 · Cited by 2
Lareyre, O., Mollevi, C., Broc, G., Caspar, M.-N., Pehlivanska, G., Boyer, H., Groc, S., Corradi, G., Loy-Morel, S., Guy, M., et al. (2024) · Women s Health · doi:10.1177/17455057241292693 · Cited by 1
Cost-Effectiveness of Home-Based Self-Sampling vs Clinician Sampling for Anal Precancer Screening
Damgacioglu, H., McAuliffe, T. L., Ridolfi, T. J., Chiao, E. Y., Fernández, M. E., Schick, V., Smith, J. S., Brzezinski, B., Nitkowski, J., Deshmukh, A. A., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.52220 · Cited by 1
Hallsson, L. R., Hoflacher, A.-M., Stratil, J. M., Muehler, M., Koch, L., John, E., Hillemanns, P., Jentschke, M., Siebert, U., & Sroczynski, G. (2026) · BMC Health Services Research · doi:10.1186/s12913-026-14409-1 · Cited by 1
Schmeink, C. E., & Bekkers, R. L. M. (2021) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-021-00539-3 · Cited by 1
Virtanen, A. (2015) · Työväentutkimus Vuosikirja
Recio, F. O., Spoo, L., Crawford, P. F., Slager, T. J., Maleck, J. M., Migliozzi, J. A., & Florida, S. (2015)
Bertucci, M., Dambroise, C., Satger, L., & Boulle, N. (2018) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(18)30178-3
Self-sampling increases cervical cancer screening uptake
(2014) · PharmacoEconomics & Outcomes News · doi:10.1007/s40274-014-1608-2
Stevens, J. (2022) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2022.12.004
Marchadier, A., Leleu, H., & Barré, S. (2023) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/j.respe.2023.101838
Pereira, S. D. G., Nobre, L., Ribeiro, M., Carvalho, P., Morais, A., Sousa, R., Moniz, A. P., Matos, F., Fernandes, G., Pimentel, J. P., et al. (2024) · medRxiv · doi:10.1101/2024.04.05.24305323
Teigné, D., Banaszuk, A.-S., Grimault, C., Lebon, A., Nanin, F., Gaultier, A., & Rat, C. (2024) · Preventive Medicine · doi:10.1016/j.ypmed.2024.108150
Contemporary Status and Frontiers of Cervical Cancer Screening in the United States
Eli, A. V., Kasten, B. B., Mayer, C., Samant, R. R., Hartman, Y. E., Chaudhary, I., Imran, N., Zotto, V. L. D., Kahn, A. G., Arend, R. C., et al. (2025) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-25-0118
Metadata
- Authors
- Haguenoer, K., Sengchanh, S., Gaudy-Graffin, C., Boyard, J., Fontenay, R., Marret, H., Goudeau, A., Pigneaux de Laroche, N., Rusch, E., & Giraudeau, B.
- Affiliations
- Inserm (FR)
- Centre Hospitalier Universitaire de Tours (FR)
- Université de Tours (FR)
- Corresponding author
- Haguenoer, K
- Venue
- British Journal of Cancer
- Published
- 2014-09-23
- Volume
- 111
- Issue
- 11
- Pages
- 2187-2196
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC4260034
- OpenAlex
- W2071793902
- Cited by
- 106
- References
- 41
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 12 · 2023: 8 · 2022: 13 · 2021: 4 · 2020: 10 · 2019: 10 · 2018: 9 · 2017: 7 · 2016: 5 · 2015: 9 · 2014: 1
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc-sa)
- Funders
- Institut National Du Cancer
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- cervical cancer screening, vaginal self-sampling, high-risk human papillomavirus testing, screening uptake, cost-effectiveness, Pap smear, HPV triage
- MeSH terms
- Adult, Aged, Uterine Cervical Neoplasms, Cost-Benefit Analysis, Female, Follow-Up Studies, Humans, Middle Aged, Patient Participation, Reagent Kits, Diagnostic, Vaginal Smears, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review